Dr Aarno Palotie
Aarno's group is mainly involved in projects investigating the genetic predisposition of traits affecting the Central Nervous System, particularly migraine, epilepsy, schizophrenia and autism.
Aarno earned his MD and PhD degrees at the University Of Oulu, Finland. He served his residency in laboratory medicine and earned his speciality in Clinical Chemistry (Clinical pathology) at the University of Helsinki.
After his residency he founded and ran the diagnostic laboratory for molecular genetics at the Helsinki University Hospital and was Professor of Cell and Molecular Biology at the University of Helsinki. From 1998 to 2002 he was Professor of Pathology at the University Of California School Of Medicine, Los Angeles. From 2002 to 2008 he was Director of the Finnish Genome Center, an independent institute at the University of Helsinki. Since 2004 he has been a visiting Professor at the Broad Institute of MIT and Harvard. He also holds a position at the Institute for Molecular Medicine Finland (FIMM) in Helsinki.
Aarno has been a Senior Researcher at the Wellcome Trust Sanger Institute since Autumn 2007. Aarno has a long history of research in genetics of Mendelian and complex traits. This has included locus and variant identification in monogenic diseases belonging to the Finnish disease heritage and linkage and association studies in complex traits. Linked to his clinical specialty and clinical duties, Aarno has a history in developing and applying new techniques for molecular diagnostics, mutation detection, physical mapping and tissue arrays.
Currently his group is studying the genetic predisposition of traits affecting the Central Nervous System: migraine, epilepsy, schizophrenia and autism. Projects are based on the use of large, well-characterised special populations and family samples. The wealth of multiple large sample sets available enables the group to use different study designs for genome variant identification, verification and effect size estimation. In collaboration with several international groups, including the International Headache Genetics Consortium, Aarno's group used data from genome-wide association studies to identify the first robust variant associated with common forms of migraine. Aarno is the co-chair of the neurodevelopmental arm of the UK10K project, which aims to sequence the exomes of 3000 schizophrenia and autism cases.
Selected Publications
Genome-wide association study reveals three susceptibility loci for common migraine in the general population.
Nature genetics2011;43;7;695-8
PUBMED: 21666692; PMC: 3125402; DOI: 10.1038/ng.856
Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1.
Nature genetics2010;42;10;869-73
PUBMED: 20802479; PMC: 2948563; DOI: 10.1038/ng.652
An immune response network associated with blood lipid levels.
PLoS genetics2010;6;9
PUBMED: 20844574; PMC: 2936545; DOI: 10.1371/journal.pgen.1001113
Distinct variants at LIN28B influence growth in height from birth to adulthood.
American journal of human genetics2010;86;5;773-82
PUBMED: 20398887; PMC: 2869010; DOI: 10.1016/j.ajhg.2010.03.010
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.
Nature genetics2009;41;12;1341-4
PUBMED: 19935662; PMC: 2804745; DOI: 10.1038/ng.490
Susceptibility loci for intracranial aneurysm in European and Japanese populations.
Nature genetics2008;40;12;1472-7
PUBMED: 18997786; PMC: 2682433; DOI: 10.1038/ng.240
The genome-wide patterns of variation expose significant substructure in a founder population.
American journal of human genetics2008;83;6;787-94
PUBMED: 19061986; PMC: 2668058; DOI: 10.1016/j.ajhg.2008.11.005
A high-density association screen of 155 ion transport genes for involvement with common migraine.
Human molecular genetics2008;17;21;3318-31
PUBMED: 18676988; PMC: 2566523; DOI: 10.1093/hmg/ddn227
Consistently replicating locus linked to migraine on 10q22-q23.
American journal of human genetics2008;82;5;1051-63
PUBMED: 18423523; PMC: 2427232; DOI: 10.1016/j.ajhg.2008.03.003
Combined genome scans for body stature in 6,602 European twins: evidence for common Caucasian loci.
PLoS genetics2007;3;6;e97
PUBMED: 17559308; PMC: 1892350; DOI: 10.1371/journal.pgen.0030097
Finding disease candidate genes by liquid association.
Genome biology2007;8;10;R205
PUBMED: 17915034; PMC: 2246280; DOI: 10.1186/gb-2007-8-10-r205
Trait components provide tools to dissect the genetic susceptibility of migraine.
American journal of human genetics2006;79;1;85-99
PUBMED: 16773568; PMC: 1474123; DOI: 10.1086/504814
PRKCA and multiple sclerosis: association in two independent populations.
PLoS genetics2006;2;3;e42
PUBMED: 16596167; PMC: 1420678; DOI: 10.1371/journal.pgen.0020042
Segmental duplications flank the multiple sclerosis locus on chromosome 17q.
Genome research2004;14;8;1483-92
PUBMED: 15256512; PMC: 509257; DOI: 10.1101/gr.2340804
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.
Proceedings of the National Academy of Sciences of the United States of America2002;99;22;14404-9
PUBMED: 12381783; PMC: 137896; DOI: 10.1073/pnas.222537099
Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24.
Human molecular genetics2002;11;19;2257-67
PUBMED: 12217954
A susceptibility locus for migraine with aura, on chromosome 4q24.
American journal of human genetics2002;70;3;652-62
PUBMED: 11836652; PMC: 384944; DOI: 10.1086/339078
Assignment of a novel locus for autosomal recessive congenital ichthyosis to chromosome 19p13.1-p13.2.
American journal of human genetics2000;66;3;1132-7
PUBMED: 10712223; PMC: 1288147; DOI: 10.1086/302813
Accurate determination of relative messenger RNA levels by RT-PCR.
Nature biotechnology1999;17;7;720-2
PUBMED: 10409357; DOI: 10.1038/10942
Characterization of a novel gene, PNUTL2, on human chromosome 17q22-q23 and its exclusion as the Meckel syndrome gene.
Genomics1999;55;1;122-5
PUBMED: 9889007; DOI: 10.1006/geno.1998.5612
Mapping ESTs by fiber-FISH.
Genome research1999;9;1;62-71

